Peer-review had a role to play when journals were all in print and competing for subscription real estate, but today it may be little more than a vestige of the print era.

As the NIH questions the place of preprints in grant applications, the U.K.’s MRC encourages scientists to submit non-peer-reviewed works for consideration.

The current peer-review system is limited to asking two people for their opinions - this is not enough.

Dame Athene Donald laments the lack of progress on gender issues

Evading science communication simply because it is difficult, time-consuming or not important enough reflects more on how much scientists value their own work and its place in posterity.

Leaving the European Union is not yet a done deal, and UK researchers must look past a pay-off and take a stand, says Colin Macilwain.

Debates over climate change and genome editing present the need for researchers to venture beyond their comfort zones to engage with citizens — and they should receive credit for doing so.

There's quite a paradox when it comes to our health data. Most of us still cannot readily look at it, but there’s been an epidemic of cybercriminals and thieves hacking and stealing this most personal information. By Eric Topol.

Four steps toward an alternative academic career.

Last year, I served on a couple NSF panels*, and I’d like to share some thoughts. Instead of a coherent narrative, I’ll just give a bulleted set of observations and ideas.

Mr. Beall’s website, which identifies “predatory open access scholarly publishers” that masquerade as scholarly journals, has grown to 923 publishers from 18 in 2011.

Universal Green OA Is the Most Efficient and Fairest of Science Publishing Strategies.

So why make your work available as preprints? There are perceived positives and negatives to disclosing scientific work in the form of a preprint, explored here in the form of 10 Simple Rules.

The EU’s fresh round of billion-euro Flagship research projects must be open to all types of science.

A Q&A with outgoing science adviser John Holdren.

This January will not only mark a new year but a new administration and with that over 4000 new presidential appointees across the federal government.  One appointment that has the potential to either hinder or benefit the biomedical research community is that of the director of the National Institutes of Health.

It’s easy for UK researchers to focus on the downsides of leaving the EU. A House of Lords report today calls for a more positive approach.

Open access publishing that permits commercial reuse enables the kinds of public-private partnerships that are essential to scientific innovation.

How a likely change in science policy in the US may result in a shift of the centre of gravity of research, particularly in certain disciplines.

The Journal Impact Factor (JIF) has been heavily criticized over decades. This opinion piece argues that the JIF should not be demonized. It still can be employed for research evaluation purposes by carefully considering the context and academic environment.

'Pick an issue on any president's agenda, and scientific literacy will be important.'

Why does a mole rat live 30 years but a mouse only three? With $1.5 billion in the bank, Google’s anti-aging spinout Calico is rich enough to find out.

Evidence to parliamentary inquiry puts some figures on the uncertainty hanging over EU university staff.

A perspective by Kathy L. Hudson and Francis S. Collins on the 21st Century Cures Act.

Elsevier explains the thought process behind its new journal impact metrics.

Sociologist Matthijs Rooduijn explains why the darkening political mood must force academics to step up and choose sides.

The measurement of Impact Factor – how many citations a publication or a researcher is able to attract, is one of the most controversial yet most widely used quality indicators in science.

How to address high tech’s missing XX factor

Promises made by researchers to participants to elicit the truth may not be worth the paper their written on if the courts can bulldoze though them.

Two men came to Zurich. Their mission: to persuade Albert Einstein to join them in Berlin...